Literature DB >> 8771372

Do etomidate and propofol influence oxygen radical production of neutrophils?

M Weiss1, A Birkhahn, M Krone, E M Schneider.   

Abstract

The effects of etomidate in an alcoholic vehicle and in a lipid-emulsion as well as those of propofol on N-formyl-methionyl-leucyl-phenylalanine (FMLP-) and zymosan-induced oxygen radical production of neutrophils were examined and compared with the effects of their respective vehicles. Furthermore free-radical scavenging capacities of these medications were investigated. The dose-response effects of etomidate, propofol and their respective vehicles on neutrophil function were tested by FMLP- and zymosan-induced chemiluminescence of neutrophils and, in addition, in a cell-free chemiluminescence system. Effects of commercial preparations of etomidate were generally not drug-specific but due to the vehicles and/or to unphysiologic osmolality values. Propofol impaired chemiluminescence of neutrophils in a drug-specific manner, even in the therapeutic concentration range. Free-radical scavenging contributed to this depression of chemiluminescence of neutrophils by propofol. Different composition of the lipid-emulsions of etomidate and propofol resulted in either a stimulation or suppression of chemiluminescence of neutrophils. Propofol but not etomidate impairs chemiluminescence of neutrophils drug-specifically. Besides a potential interaction with the neutrophils, free-radical scavenging accounts for this suppression.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8771372     DOI: 10.3109/08923979609052737

Source DB:  PubMed          Journal:  Immunopharmacol Immunotoxicol        ISSN: 0892-3973            Impact factor:   2.730


  3 in total

1.  Effects of propofol vs methohexital on neutrophil function and immune status in critically ill patients.

Authors:  Egbert Huettemann; Annabell Jung; Heinz Vogelsang; Nicole van Hout; Samir G Sakka
Journal:  J Anesth       Date:  2006       Impact factor: 2.078

2.  Effect of propofol on adhesion of activated platelets to leukocytes in human whole blood.

Authors:  Lothar de Rossi; Martina Wessiepe; Wolfgang Buhre; Ralf Kuhlen; Gabriele Hutschenreuter; Rolf Rossaint
Journal:  Intensive Care Med       Date:  2003-06-11       Impact factor: 17.440

3.  Protective activity of propofol, Diprivan and intralipid against active oxygen species.

Authors:  M Mathy-Hartert; G Deby-Dupont; P Hans; C Deby; M Lamy
Journal:  Mediators Inflamm       Date:  1998       Impact factor: 4.711

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.